Johnson Health Tech Co's ROE % for the quarter that ended in Dec. 2025 was 54.74%. Johnson Health Tech Co's PB Ratio for the quarter that ended in Dec. 2025 was 3.34.
Johnson Health Tech Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 16.39%.
Johnson Health Tech Co ROE % Adjusted to Book Value Related Terms
Johnson Health Tech Co ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Johnson Health Tech Co's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Johnson Health Tech Co ROE % Adjusted to Book Value Chart
TPE:1736 vs AS, HAS, LTH: ROE % Adjusted to Book Value Comparison
For the Leisure subindustry, Johnson Health Tech Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Johnson Health Tech Co ROE % Adjusted to Book Value vs Travel & Leisure Industry
For the Travel & Leisure industry and Consumer Cyclical sector, Johnson Health Tech Co's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Johnson Health Tech Co's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 16.39% mean?
Johnson Health Tech Co (TPE:1736) has a ROE % Adjusted to Book Value of 16.39% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Johnson Health Tech Co and its competitors.
Is Johnson Health Tech Co's ROE % Adjusted to Book Value too high?
Johnson Health Tech Co's current ROE % Adjusted to Book Value is 16.39%. Overall, Johnson Health Tech Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Johnson Health Tech Co's ROE % Adjusted to Book Value compare to AS and HAS?
Johnson Health Tech Co's ROE % Adjusted to Book Value of 16.39% can be compared against companies in the Travel & Leisure industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Travel & Leisure company?
A good ROE % Adjusted to Book Value depends on the Travel & Leisure industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Johnson Health Tech Co and its competitors. Johnson Health Tech Co's current ROE % Adjusted to Book Value is 16.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson Health Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Johnson Health Tech Co (TPE:1736) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$156.20, compared to a current price of NT$131.50 — trading 15.8% below its estimated fair value. The current ROE % Adjusted to Book Value is 16.39%. Johnson Health Tech Co's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Johnson Health Tech Co (TPE:1736), the current ROE % Adjusted to Book Value is 16.39% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Johnson Health Tech Co (TPE:1736) Overvalued in 2026?
Based on GuruFocus' analysis, Johnson Health Tech Co stock appears to be undervalued.
The current stock price of NT$131.50 is trading 15.8% below its estimated GF Value™ of NT$156.20.
GuruFocus considers Johnson Health Tech Co to be Modestly Undervalued.
Key valuation signals for TPE:1736:
ROE % Adjusted to Book Value: 16.39%
GF Value™: NT$156.20 vs. price of NT$131.50 (15.8% below fair value)
No single metric tells the full story. See the TPE:1736 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Johnson Health Tech Co Ltd is engaged in the manufacturing and selling of sports equipment, cardio equipment, weight training equipment, and related electronic components. It operates in a single industry segment with four strategic segments: American segment: In charge of selling cardiovascular equipment and research and development of training equipment in America; European segment: In charge of selling cardiovascular equipment in Europe; Asian segment: In charge of manufacturing and selling Fuji massage chairs, cardiovascular equipment and weight training equipment in Asia, and franchising the import and export of the above-mentioned products; and Others: In charge of selling cardiovascular machinery in other areas. Geographically, it operates in the Americas, Europe, Asia, and Other.
83GF Score
Get the complete analysis for TPE:1736
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1736 has been successfully added to your 
